{"nct_id":"NCT02760485","title":"A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","status":"COMPLETED","status_verified_date":"2023-06","start_date":"2016-12-29","start_date_type":"ACTUAL","primary_completion_date":"2022-06-06","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-06","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}